NAD+ and Long COVID
NAD+ and Long COVID: What a New Clinical Trial Reveals About Fatigue Recovery
Persistent fatigue is one of the most debilitating symptoms of long COVID. For many patients, it’s not just “feeling tired,” it’s a profound lack of cellular energy that impacts cognition, mood, and daily function. A recent randomized controlled trial exploring nicotinamide riboside (NR) offers important insight into a potential path forward: restoring NAD+.
Why NAD+ Matters in Long COVID
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme essential for mitochondrial function, which is the process by which your cells produce energy. In conditions of chronic inflammation and viral stress, like long COVID, NAD+ levels are often depleted. This depletion is closely linked to fatigue, brain fog, poor sleep, and reduced resilience at the cellular level.
What the Study Found
Participants who took NR experienced a measurable increase in NAD+ levels. This confirms that targeting NAD+ is a biologically relevant strategy in long COVID recovery.
More notably, after approximately 10 weeks of supplementation, researchers observed potential improvements in fatigue, cognitive function, sleep quality, and depressive symptoms in some individuals.
However, these improvements were exploratory and not consistently significant across all participants compared to placebo.
The Missing Link: Conversion Efficiency
Here’s where the findings become especially important.
NR is not NAD+ itself—it is a precursor. In order to be useful, the body must convert NR into NAD+ through a series of enzymatic steps. This process depends on metabolic health, enzyme availability, and cellular function.
In individuals with long COVID, where inflammation, mitochondrial dysfunction, and metabolic disruption are common, this conversion pathway may be compromised.
In practical terms, that means:
You may be taking in a precursor
But your body may not efficiently convert it
Resulting in limited clinical benefit
This helps explain why increases in NAD+ levels don’t always translate into meaningful symptom relief.
Why Direct NAD+ Matters
At NADPLUS, we take a different approach.
Instead of relying on the body to convert a precursor, we focus on delivering NAD+ in its most bioavailable form, bypassing the need for conversion altogether.
This matters because:
It allows for immediate cellular uptake
It supports mitochondrial function more directly
It reduces reliance on impaired metabolic pathways
For individuals experiencing persistent fatigue, this can make a meaningful difference in how effectively the body restores energy at the cellular level.
What This Means for Recovery
This study reinforces a critical point: NAD+ depletion is a real and relevant driver of long COVID symptoms.
But it also highlights that how we restore NAD+ matters just as much as whether we restore it.
For patients navigating long COVID, especially those dealing with ongoing fatigue and cognitive symptoms, optimizing NAD+ availability, without relying solely on conversion, which may offer a more effective path forward.
As research continues to evolve, one thing is becoming increasingly clear: supporting cellular energy is central to recovery.
And NAD+ sits at the heart of that process.